AP
GILD icon

Adero Partners’s Gilead Sciences GILD Stock Holding History

Adero Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$296K Buy
2,642
+156
+6% +$16.1K 0.02% 177
2024
Q4 		$230K Buy
+2,486
New +$224K 0.01% 213

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Adero Partners's GILD Position: Q1 2025 in Review

Adero Partners increased its Gilead Sciences (GILD) stake by 6.3% in Q1 2025, buying an estimated $16.1K and bringing the position to 2,642 shares worth $296K. The position accounts for 0.02% of the portfolio, ranked #177.

Adero Partners first reported a position in GILD in Q4 2024 and has held it in 2 quarters since. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Adero Partners held 2,642 shares of Gilead Sciences worth $296K as of Q1 2025.
  • Adero Partners bought 156 Gilead Sciences shares in Q1 2025, an estimated $16.1K.
  • Gilead Sciences made up 0.02% of Adero Partners's portfolio in Q1 2025, its #177 holding.
  • Adero Partners first reported a position in Gilead Sciences in Q4 2024 and has held it in 2 quarters since.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Adero Partners's 13F filing for Q1 2025, filed 17 Apr 2025.